Breakthrough Technologies for Optogenetics

  • Lightweight
  • Battery Free
  • Implantable
  • Ultraminiaturized

NeuroLux News

posted: 2020-11-16

Novel NeuroLux Optofluidics Device

  NeuroLux has launched the first commercially manufactured Optofluidics device, providing simultaneous drug delivery and optogenetics. It is an implantable, lightweight, battery-free device with parameter control on the individual device level. The device combines soft microfluidic and microscale inorganic light-emitting diode probes for programmable pharmacological and optogenetics, designed to offer the features of drug refillability and adjustable […]

posted: 2020-07-28

NeuroLux Remote Workshop

NeuroLux is extending its reach to China as the global provider of breakthrough technologies for optogenetics. Its first international remote workshop invites the neuroscience community across China to get familiar with the NeuroLux system, devices and to interact with engineers behind the technology.  Event Details: Platform: Zoom Date: August 11, 2020, or August 12, 2020 […]

posted: 2019-05-31

Tuning Made Easy: NeuroLux Launches the Autotuner

NeuroLux has launched the Autotuner, an upgrade to the manual Antenna Tuner Box which matches the impedance of the source and the antenna. This step is crucial to the overall performance of the NeuroLux system, with accurate tuning corresponding to maximized power transfer to the implantable devices in any antenna configuration, and lab environment. However, […]

Full News Archive